The U.S. Securities and Exchange Commission on Thursday accused a healthcare company executive of misappropriating more than $10 million from investors who were told their money would be used to develop cancer screening and treatment technology. In a complaint filed in Massachusetts federal court, the SEC alleges that Sumit Rai, the chief executive of NVS
The U.S. Securities and Exchange Commission on Thursday accused a healthcare company executive of misappropriating more than $10 million from investors who were told their money would be used to develop cancer screening and treatment technology.
In a… [3000 chars]
Source: USA Herald | Published: 2026-01-16T09:46:54Z
Credit: USA Herald
